Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
13.69
+0.26 (1.94%)
At close: Mar 13, 2026, 4:00 PM EDT
13.72
+0.03 (0.22%)
After-hours: Mar 13, 2026, 7:00 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Specialty Nutrition Systems (sns)
432.90M396.40M---
Specialty Nutrition Systems (sns) Growth
9.21%----
Pain Management and Recovery (pm&r)
237.80M234.20M---
Pain Management and Recovery (pm&r) Growth
1.54%----
Corporate and Other
30.50M57.20M---
Corporate and Other Growth
-46.68%----
Medical Devices
---684.10M587.00M
Medical Devices Growth
---16.54%-17.88%
Total
701.20M687.80M-684.10M587.00M
Total Growth
1.95%--16.54%-17.88%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
North America
543.90M545.00M537.90M552.00M449.10M
North America Growth
-0.20%1.32%-2.55%22.91%-
Europe, Middle East and Africa (EMEA)
102.80M94.80M84.10M77.40M86.10M
Europe, Middle East and Africa (EMEA) Growth
8.44%12.72%8.66%-10.10%-20.50%
Asia Pacific and Latin America
54.50M48.00M51.30M54.70M51.80M
Asia Pacific and Latin America Growth
13.54%-6.43%-6.22%5.60%-27.04%
Total
701.20M687.80M673.30M684.10M587.00M
Total Growth
1.95%2.15%-1.58%16.54%-17.88%
Source: S&P Global Market Intelligence.